MedPharm have been named ‘Best Contract Topical & Transdermal Product Design Agency’ in the GHP Biotechnology Awards 2018.

These awards strive to recognise and spotlight the key players within this ever-evolving and ground-breaking industry, and MedPharm are delighted to have been announced as winners.

MedPharm’s industry leading performance testing capabilities give our clients and their potential investors the confidence they need regarding the penetration, target engagement and disease activity of drug at the site of action in order to de-risk expensive and complex clinical trials. At MedPharm performance tests are an integral part of any formulation development program and can be used strategically throughout the development process to mitigate development risks and failures due to inadequate product performance.

MedPharm remains at the forefront of innovation in the development of new models for assessing the activity as well as permeation and penetration of drugs in human skin. The high level of automation incorporated means that the data created is within tighter tolerances than other existing options. This is crucial for clients who are looking to convince regulators of their generic products bioequivalence to the originator or others who are looking to find patentable differences for their products.

Thank you to everyone that voted for us!

More details on the awards are available here.

Back to News